Genprex, Inc. (GNPX)
NASDAQ · Manufacturing · Pharmaceutical preparations
GNPX price, last 12 months
Key stats
- Previous close
- $1.71
- Open
- $1.72
- Day range
- $1.63 – $1.80
- 52-week range
- $1.45 – $80.96
- Volume
- 63.6K
- Avg volume (20 days)
- 131.4K
- Market cap
- $1.7M
Performance
Technicals and fundamentals
About Genprex, Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.7M